On May 1, China Chamber of Commerce for Import and Export of Pharmaceuticals and Health Products Zhou Hui and his entourage to investigate and guide the 137th Canton Fair participation in the work of Huihong Pharmaceuticals, Su hao Holdings Group Vice President Ding Hai accompanied the investigation.
Ding Hai thanked the Chamber of Commerce on the development of Soho Holding Group care and support, introduced Soho Holding Group and Huihong pharmaceutical company in the first quarter of foreign trade business situation, said Soho Holding Group is seizing the opportunity of reform and development, and actively integrated into the high-quality construction of the “One Belt, One Road” and other national strategies, and vigorously promote the platform of the “Central Asia Jiangsu Center” and other platforms. Central Asia Jiangsu Center” and other platform construction, in Africa, Southeast Asia and other places to improve the layout, enhance the level of overseas development. He said, Huihong Pharmaceutical Company, as a subsidiary of Soho Holding Group specializing in the operation of pharmaceutical and medical equipment products, and actively respond to the new situation and new changes in the external environment, the fair launched with independent intellectual property rights of the appearance of the design, to enrich the super, cinema, and other product categories, on the basis of the solid traditional market, and actively develop new markets and new customers, expanding the trade of intermediate products, the first day of the exhibition attracted multinational On the first day of the exhibition, it attracted buyers from many countries to stop and negotiate, and achieved good results.
Zhou Hui highly recognized the strategic layout of the Soho Holding Group, Huihong Pharmaceutical Company, as a key member of the Chamber of Commerce, adhere to the “specialization, specialization, branding” development path, in recent years, to achieve better development results. He encouraged the pharmaceutical company to take advantage of the “window advantage” of the Canton fair, continue to introduce new products and new designs, increase efforts to expand the “Belt and Road” and other emerging markets, and actively respond to the U.S. tariff adjustments, seize the business opportunities to enhance the core competitive advantage for the pharmaceutical foreign trade business to make more contributions. He said that the Chamber will continue to contribute to the cause of pharmaceutical foreign trade. He said, the chamber will continue to support the development of Huihong pharmaceutical company, play a good role as a bridge between enterprises and the government, the international market, for the pharmaceutical company to provide assistance for the innovative and high-quality development.
